EDéžå¤„æ–¹è¯ä¸Žä¿å¥å“：安全性ã€é£Žé™ 与€‰è´­æŒ‡å—: Revision history

17 December 2025

• curprev 16:2516:25, 17 December 2025 DonnieMcNamara talk contribs m 5,766 bytes −6 No edit summary undo
• curprev 07:3207:32, 17 December 2025 ConcettaBoisvert talk contribs m 5,772 bytes +511 No edit summary undo

15 December 2025

• curprev 15:4215:42, 15 December 2025 MohammadChinn21 talk contribs m 5,261 bytes +212 No edit summary undo

2 December 2025

• curprev 07:4107:41, 2 December 2025 RhondaMuller9 talk contribs m 5,049 bytes +294 No edit summary undo

9 November 2025

• curprev 21:0721:07, 9 November 2025 RochelleGoldschm talk contribs m 4,755 bytes −2,084 No edit summary undo

3 November 2025

• curprev 07:5007:50, 3 November 2025 PamRohr246998282 talk contribs m 6,839 bytes −145 No edit summary undo

17 October 2025

• curprev 01:0101:01, 17 October 2025 IndianaDougherty talk contribs 6,984 bytes +6,984 Created page with "<br><br><br>在第24周时，MED3000组61%的使用者表示勃起状态较基线有明显改善，国际勃起功能指数量表评分平均提高5.73分，并有85%的使用者表示"使用后可以出现自发性行为"，并没有严重的不良事件。 Eroxon ®在美国获得 FDA 批准，在欧洲获得 CE 认证，在英国获得 UKCA Buy Rivotril 认证，作为 Eroxon ®品牌下针对成年男性勃起功能障碍的经临床证明的局部治疗..."